PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation

Cell Death and Differentiation

Volumn 19, Issue 7, 2012, Pages 1127-1138

  Iovino, S ^a   Oriente, F ^a   Botta, G ^a   Cabaro, S ^a   Iovane, V ^a   Paciello, O ^a   Viggiano, D ^b   Perruolo, G ^a   Formisano, P ^a   Beguinot, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

autophagy; PED PEA 15; skeletal muscle differentiation; TGF beta1

Indexed keywords

3 METHYLADENINE; GLUCOSE TRANSPORTER 4; MYOD1 PROTEIN; MYOGENIN; PED PEA 15; PHOSPHOPROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; IN VIVO STUDY; LOCOMOTION; MOUSE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADENINE; ANIMALS; ASTROCYTES; AUTOPHAGY; CARBOXYLIC ESTER HYDROLASES; CELL LINE; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; PHOSPHOPROTEINS; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1;

MUS; MUS MUSCULUS;

EID: 84862133224     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.201     Document Type: Article

References (42)

1. Ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004; 29: 265-273.
2. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
3. Dai C, Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-b1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004; 15: 1402-1412.
4. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-161.
5. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463-470.
6. Toda S, Matsumura S, Fujitani N, Nishimura T, Yonemitsu N, Sugihara H. Transforming growth factor-beta1 induces a mesenchyme-like cell shape without epithelial polarization in thyrocytes and inhibits thyroid folliculogenesis in collagen gel culture. Endocrinology 1997; 138: 5561-5575.
7. Massague J, Cheifetz S, Endo T, Nadal-Ginard B. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci 1986; 83: 8206-8210.
8. Kollias HD, McDermott JC. Transforming growth factor-beta and myostatin signaling in skeletal muscle. J Appl Physiol 2008; 104: 579-587.
9. Schabort EJ, Van Der Merwe M, Loos B, Moore FP, Niesler CU. TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner. Exp Cell Res 2009; 315: 373-384.
10. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005; 37: 1974-1984.
11. Sandri M. Autophagy in skeletal muscle. FEBS 2010; 584: 1411-1416.
12. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6: 472-483.
13. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M et al. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10: 507-515.
14. Suzuki HI, Kiyono K, Miyazono K. Regulation of autophagy by transforming growth factorbeta (TGFbeta) signaling. Autophagy 2010; 14: 6.
15. Araujo H, Danziger N, Cordier J, Glowinski J, Chneiweiss H. Characterization of PEA-15 a major substrate for protein kinase C in astrocytes. J Biol Chem 1993; 268: 5911-5920.
16. Fiory F, Formisano P, Perruolo G, Beguinot F. Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab 2009; 297: 592-601.
17. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F et al. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 1998; 7: 3858-3866.
18. Valentino R, Lupoli G, Raciti GA, Oriente F, Farinaro E, Della Valle E et al. The PEA15 gene is overexpressed and related to insulin resistance in healthy first degree relatives of patients with type 2 diabetes. Diabetologia 2006; 49: 3058-3066.
19. Oriente F, Iovino S, Cassese A, Romano C, Miele C, Troncone G et al. Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. Diabetologia 2009; 52: 2642-2652.
20. Böck BC, Tagscherer KE, Fassl A, Krämer A, Oehme I, Zentgraf HW et al. The PEA-15 protein regulates autophagy via activation of JNK. J Biol Chem 2010; 285: 21644-21654.
21. Pisani DF, Cabane C, Derijard B, Dechesne CA. The topoisomerase 1-interacting protein BTBD1 is essential for muscle cell differentiation. Cell Death Differ 2004; 11: 1157-1165.
22. Salih DA, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 2008; 20: 126-136.
23. Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009; 284: 28319-28331.
24. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117: 399-412.
25. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004; 279: 41114-41123.
26. Vigliotta G, Miele C, Santopietro S, Portella G, Perfetti A, Maitan MA et al. Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol 2004; 24: 5005-5015.
27. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ. Myostatin reduces Akt/TORC1/p70S6 K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 2009; 296: 1258-1270.
28. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 2009; 296: 1248-1257.
29. Kollias HD, McDermott JC. Transforming growth factor-b and myostatin signaling in skeletal muscle. J Appl Physiol 2007; 104: 579-587.
30. Meléndez A, Neufeld TP. The cell biology of autophagy in metazoans: a developing story. Development 2008; 135: 2347-2360.
31. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990-995.
32. Vellai T, Bicsák B, Tó th ML, Taká cs-Vellai K, Kovács AL. Regulation of cell growth by autophagy. Autophagy 2008; 4: 507-509.
33. Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R et al. Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice. Cancer Gene Ther 2007; 14: 945-952.
34. Yan L, Lavin VA, Moser LR, Cui Q, Kanies C, Yang E. PP2A regulates the pro-apoptotic activity of FOXO1. J Biol Chem 2008; 283: 7411-7420.
35. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868.
36. Petritsch C, Beug H, Balmain A, Oft M. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 2000; 14: 3093-3101.
37. Renault-Mihara F, Beuvon F, Iturrioz X, Canton B, De Bouard S, Léonard N et al. Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell 2006; 17: 5141-5152.
38. Zhang D, Kanthasamy A, Yang Y, Anantharam V, Kanthasamy A. Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J Neurosci 2007; 27: 5349-5362.
39. Caruso M, Miele C, Formisano P, Condorelli G, Bifulco G, Oliva A et al. In skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J Biol Chem 1997; 272: 7290-7297.
40. Mignogna P, Viggiano D. Brain distribution of genes related to changes in locomotor activity. Physiol Behav 2010; 19: 618-626.
41. Paciello O, Papparella S. Histochemical and immunohistological approach to comparative neuromuscular diseases. Folia Histochem Cytobiol 2009; 47: 143-152.
42. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.